Is Amgen Stock Underperforming the Nasdaq?

Amgen Inc. (AMGN) is a leading biopharmaceutical company that discovers, develops, manufactures, and delivers human therapeutics for serious illnesses. Headquartered in Thousand Oaks, California, Amgen has a market capitalization of around $180 billion, making it one of the largest biotech firms in the world. Companies with a market cap of $10 billion or more are typically recognized as “large-cap stocks”, a classification that reflects their financial heft, robust performance, and global market presence, ...